|
1
|
Mimura S, Ito Y, Nagayo T, et al:
Cooperative clinical trial of photodynamic therapy with photofrin
II and excimer dye laser for early gastric cancer. Lasers Surg Med.
19:168–172. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mlkvy P, Messmann H, Pauer M, et al:
Distribution and photodynamic effects of
meso-tetrahydroxyphenylchlorin (mTHPC) in the pancreas and adjacent
tissues in the Syrian golden hamster. Br J Cancer. 73:1473–1479.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yamamoto J, Hirano T, Li S, et al:
Selective accumulation and strong photodynamic effects of a new
photosensitizer, ATX-S10. Na (II), in experimental malignant
glioma. Int J Oncol. 27:1207–1213. 2005.PubMed/NCBI
|
|
4
|
Stummer W, Pichlmeier U, Meinel T, et al:
Fluorescence-guided surgery with 5-aminolevulinic acid for
resection of malignant glioma: a randomised controlled multicentre
phase III trial. Lancet Oncol. 7:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Muller PJ and Wilson BC: Photodynamic
therapy for malignant newly diagnosed supratentorial gliomas. J
Clin Laser Med Surg. 14:263–270. 1996.PubMed/NCBI
|
|
6
|
Yamamoto J, Yamamoto S, Hirano T, et al:
Monitoring of singlet oxygen is useful for predicting the
photodynamic effects in the treatment for experimental glioma. Clin
Cancer Res. 12:7132–7139. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Schaffer M, Ertl-Wagner B, Schaffer PM, et
al: Feasibility of photofrin II as a radiosensitizing agent in
solid tumors - preliminary results. Onkologie. 29:514–519. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Luksiene Z, Juzenas P and Moan J:
Radiosensitization of tumours by porphyrins. Cancer Lett.
235:40–47. 2006. View Article : Google Scholar
|
|
9
|
Berg K, Luksiene Z, Moan J and Ma L:
Combined treatment of ionizing radiation and photosensitization by
5-aminolevulinic acid-induced protoporphyrin IX. Radiat Res.
142:340–346. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schaffer M, Schaffer PM, Jori G, et al:
Radiation therapy combined with photofrin or 5-ALA: effect on Lewis
sarcoma tumor lines implanted in mice. Preliminary results. Tumori.
88:407–410. 2002.PubMed/NCBI
|
|
11
|
Takahashi J, Misawa M, Murakami M, et al:
5-Aminolevulinic acid enhances cancer radiotherapy in a mouse tumor
model. Springerplus. 2:6022013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto J, Ogura S, Tanaka T, et al:
Radiosensitizing effect of 5-aminolevulinic acid-induced
protoporphyrin IX in glioma cells in vitro. Oncol Rep.
27:1748–1752. 2012.PubMed/NCBI
|
|
13
|
Benda P, Someda K, Messer J and Sweet WH:
Morphological and immunochemical studies of rat glial tumors and
clonal strains propagated in culture. J Neurosurg. 34:310–323.
1971. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidek HH, Nielsen SL, Schiller AL and
Messer J: Morphological studies of rat brain tumors induced by
N-nitrosomethylurea. J Neurosurg. 34:335–340. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barth RF: Rat brain tumor models in
experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2
and CNS-1 gliomas. J Neurooncol. 36:91–102. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hagiya Y, Fukuhara H, Matsumoto K, et al:
Expression levels of PEPT1 and ABCG2 play key roles in
5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin
IX (PpIX) accumulation in bladder cancer. Photodiagnosis Photodyn
Ther. 10:288–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ishizuka M, Hagiya Y, Mizokami Y, et al:
Porphyrins in urine after administration of 5-aminolevulinic acid
as a potential tumor marker. Photodiagnosis Photodyn Ther.
8:328–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cerniglia GJ, Wilson DF, Pawlowski M,
Vinogradov S and Biaglow J: Intravascular oxygen distribution in
subcutaneous 9L tumors and radiation sensitivity. J Appl Physiol.
82:1939–1945. 1997.PubMed/NCBI
|
|
19
|
Abels C, Heil P, Dellian M, et al: In vivo
kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence
in an amelanotic melanoma of the hamster. Br J Cancer. 70:826–833.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abels C, Fritsch C, Bolsen K, et al:
Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins
of an amelanotic melanoma in vivo. J Photochem Photobiol B.
40:76–83. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bozzini G, Colin P, Betrouni N, et al:
Efficiency of 5-ALA mediated photodynamic therapy on hypoxic
prostate cancer: a preclinical study on the Dunning R3327-AT2 rat
tumor model. Photodiagnosis Photodyn Ther. 10:296–303. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niclou SP, Danzeisen C, Eikesdal HP, et
al: A novel eGFP-expressing immunodeficient mouse model to study
tumor-host interactions. FASEB J. 22:3120–3128. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Prall F, Maletzki C and Linnebacher M:
Microdensitometry of osteopontin as an immunohistochemical
prognostic biomarker in colorectal carcinoma tissue microarrays:
potential and limitations of the method in ‘biomarker pathology’.
Histopathology. 61:823–832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kostron H, Swartz MR, Miller DC and
Martuza RL: The interaction of hematoporphyrin derivative, light,
and ionizing radiation in a rat glioma model. Cancer. 57:964–970.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ito E, Yue S, Moriyama EH, et al:
Uroporphyrinogen decarboxylase is a radiosensitizing target for
head and neck cancer. Sci Transl Med. 3:67ra72011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
David S and Kroner A: Repertoire of
microglial and macrophage responses after spinal cord injury. Nat
Rev Neurosci. 12:388–399. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lynch MA: The multifaceted profile of
activated microglia. Mol Neurobiol. 40:139–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
MacMicking J, Xie QW and Nathan C: Nitric
oxide and macrophage function. Annu Rev Immunol. 15:323–350. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boehm U, Klamp T, Groot M and Howard JC:
Cellular responses to interferon-gamma. Annu Rev Immunol.
15:749–795. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hussain SF, Yang D, Suki D, Grimm E and
Heimberger AB: Innate immune functions of microglia isolated from
human glioma patients. J Transl Med. 4:152006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li W and Graeber MB: The molecular profile
of microglia under the influence of glioma. Neuro Oncol.
14:958–978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Filipazzi P, Huber V and Rivoltini L:
Phenotype, function and clinical implications of myeloid-derived
suppressor cells in cancer patients. Cancer Immunol Immunother.
61:255–263. 2012. View Article : Google Scholar
|
|
33
|
Skivka LM, Gorobets OB, Kutsenok VV, et
al: 5-aminolevulinic acid mediated photodynamic therapy of Lewis
lung carcinoma: a role of tumor infiltration with different cells
of immune system. Exp Oncol. 26:312–315. 2004.
|
|
34
|
Ishizuka M, Abe F, Sano Y, et al: Novel
development of 5-aminolevurinic acid (ALA) in cancer diagnoses and
therapy. Int Immunopharmacol. 11:358–365. 2011. View Article : Google Scholar
|
|
35
|
Higashikawa F, Noda M, Awaya T, Tanaka T
and Sugiyama M: 5-aminolevulinic acid, a precursor of heme, reduces
both fasting and postprandial glucose levels in mildly
hyperglycemic subjects. Nutrition. 29:1030–1036. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Starke RM, Williams BJ, Hiles C, et al:
Gamma knife surgery for skull base meningiomas. J Neurosurg.
116:588–597. 2012. View Article : Google Scholar
|
|
37
|
Torres RC, Frighetto L, De Salles AA, et
al: Radiosurgery and stereotactic radiotherapy for intracranial
meningiomas. Neurosurg Focus. 14:e52003. View Article : Google Scholar
|
